A Randomized, Open, Parallel, Multicenter, Phase 4 Study to Evaluate the Central Aortic Pressure Effect Between Fixed Dose Combination (Duowell® Tab) and Monotherapy of Telmisartan in Mild Dyslipidemia Patients With Hypertension
Phase of Trial: Phase IV
Latest Information Update: 15 Apr 2019
Price : $35 *
At a glance
- Drugs Rosuvastatin/telmisartan (Primary) ; Telmisartan
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Sponsors Yuhan
- 10 Apr 2019 Planned End Date changed from 1 Oct 2018 to 1 Dec 2018.
- 10 Apr 2019 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2018.
- 10 Apr 2019 Status changed from not yet recruiting to recruiting.